SCHEMBL6344238

SCHEMBL6344238

Clc1c2ccccc2nc2c1c(CBr)nn2-c1ccccn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.38
KDM4E B2RXH2 6/20 0.38
MAPT P10636 3/20 0.38
HPGD P15428 2/20 0.38
GAA P10253 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
HTT P42858 2/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
AURKA O14965 1/20 0.36
FLT3 P36888 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
RAB9A P51151 2/20 0.36
KMT2A Q03164 5/20 0.35
USP2 O75604 1/20 0.35
TSHR P16473 1/20 0.35
METAP1 P53582 1/20 0.35
NPC1 O15118 1/20 0.34
HK1 P19367 1/20 0.34
HKDC1 Q2TB90 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6341853 0.89 CCNE2 (0.40) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL6343061 0.82 ALDH1A1 (0.46) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL6342834 0.82 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL6342932 0.80 NR3C1 (0.37) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL6344682 0.80 PIK3CD (0.39) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL6344817 0.76 MAOA (0.46) ALDH1A1KDM4EHPGDMAOAMAOB
SCHEMBL6342619 0.75 CCNE2 (0.39) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL6342505 0.75 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL6343804 0.74 KDM4E (0.50) ALDH1A1KDM4EMAPTHPGDNPSR1
SCHEMBL6340244 0.74 SPR (0.47) ALDH1A1KDM4EMAPTHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 ALDH1A1 1061/4885KDM4E 1741/4885MAPT 3408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.